此后十年，他在基因筛选（CRISPR筛选）和病原体核酸检测（CRISPR诊断）等多个领域做出开创性研究，对生命科学和生物医药等领域产生了革命性影响。 除CRISPR-Cas9之外，张锋还对光遗传学做出了 ...

CRISPR/Cas和Argonaute（Ago）可编程核酸酶与等温扩增技术的偶联，有效解决了等温扩增技术，如RPA、LAMP的特异性差、难以多重检测的局限性，为即时检测（POCT）提供了新的解决方案。然而，由于 ...

导读近日，华人学者张锋再获大奖。此次获得的奖项是美国科学技术领域的最高荣誉。MIT理学院院长表示，“张锋是CRISPR技术领域的杰出研究者之一，该技术加速了科学与工程的进步，融合了创业精神与科学发现。” 林 岩 | 撰文01张锋再获大奖 ...

Get Instant Summarized Text (Gist) CRISPR nucleases, Cas9 and Cas12, have been engineered to evade immune detection, addressing a key challenge in CRISPR-based therapies. By identifying and ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell.

CRISPR/Cas9使得在基因组特定位置 ... 这些研究的目标是理解、诊断和治疗疾病。我们的发表政策既包括对具有广泛兴趣和重要性的研究的选择倾向 ...

Then Crispr came along—the elegant enzymatic apparatus that allows delivery of DNA scissors to a specific target in the genome. In December 2023, the FDA approved the first Crispr-based therapy ...

ZUG, Switzerland and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

此后十年，他在基因筛选（CRISPR筛选）和病原体核酸检测（CRISPR诊断）等多个领域做出开创性研究，对生命科学和生物医药等领域产生了革命性影响。